Literature DB >> 26149635

Visceral adiposity index, hypertriglyceridemic waist phenotype and chronic kidney disease in a southern Chinese population: a cross-sectional study.

Jun Huang1, Chaomin Zhou, Yongqiang Li, Shuangshuang Zhu, Aiqun Liu, Xiaofei Shao, Xinyu Liu, Harry Holthfer, Hequn Zou.   

Abstract

OBJECTIVE: To explore the relationships between visceral adiposity index (VAI), hypertriglyceridemic waist phenotype (HW phenotype) and chronic kidney disease (CKD).
METHODS: A cross-sectional study was conducted in Zhuhai City June-October 2012. A total of 2142 participants were recruited. Logistic regression was used to evaluate the associations between VAI, HW phenotype and CKD.
RESULTS: After adjustment for age, VAI was significantly associated with CKD (OR 2.16, 95 % CI 1.25-3.74, P = 0.006) in women. Further adjusted for potential confounders, the association was still significant in women (OR 2.07, 95 % CI 1.17-3.64, P = 0.01). However, the association was abolished when adding diabetes and hypertension to the model (OR 1.68, 95 % CI 0.92-3.06, P = 0.09). The age-adjusted OR (95 % CI, P) of CKD associated with HW phenotype was 2.21 (1.29-3.76, 0.004) and 2.54 (1.53-4.22, <0.001) for men and women, respectively. Further adjusted for potential confounders, the associations were still significant in both subgroups. The OR for CKD was 2.41 (95 % CI 1.42-4.12, P = 0.001) and 2.32 (95 % CI 1.31-4.11, P = 0.004) for women and men, respectively. When further adjusted for diabetes and hypertension, the association of HW phenotype and CKD was significant (OR 1.88, 95 % CI 1.05-3.36, P = 0.033) in women. However, the model is abolished in men (OR 1.50, 95 % CI 0.81-2.78, P = 0.19).
CONCLUSION: Our results suggest that both VAI and the HW phenotype might be useful clinical indicators of CKD in China for females but not for males. The HW phenotype associated more strongly with CKD, compared with VAI.

Entities:  

Mesh:

Year:  2015        PMID: 26149635     DOI: 10.1007/s11255-015-1040-y

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  33 in total

1.  Assessing adiposity: a scientific statement from the American Heart Association.

Authors:  Marc-Andre Cornier; Jean-Pierre Després; Nichola Davis; Daurice A Grossniklaus; Samuel Klein; Benoit Lamarche; Francisco Lopez-Jimenez; Goutham Rao; Marie-Pierre St-Onge; Amytis Towfighi; Paul Poirier
Journal:  Circulation       Date:  2011-09-26       Impact factor: 29.690

2.  Relationship of visceral and subcutaneous adiposity with renal function in people with type 2 diabetes mellitus.

Authors:  Sung Rae Kim; Ji Han Yoo; Ho Cheol Song; Seong Su Lee; Soon Jib Yoo; Young-Du Kim; Yeon Soo Lim; Hyung Wook Kim; Chul Woo Yang; Yong-Soo Kim; Euy Jin Choi; Yong Kyun Kim
Journal:  Nephrol Dial Transplant       Date:  2010-10-28       Impact factor: 5.992

3.  Abdominal obesity, muscle composition, and insulin resistance in premenopausal women.

Authors:  Robert Ross; Jennifer Freeman; Robert Hudson; Ian Janssen
Journal:  J Clin Endocrinol Metab       Date:  2002-11       Impact factor: 5.958

4.  Chronic renal diseases as a public health problem: epidemiology, social, and economic implications.

Authors:  Arrigo Schieppati; Giuseppe Remuzzi
Journal:  Kidney Int Suppl       Date:  2005-09       Impact factor: 10.545

Review 5.  Prevention of the progression of chronic kidney disease: practice in China.

Authors:  Haiyan Wang; Luxia Zhang; Jicheng Lv
Journal:  Kidney Int Suppl       Date:  2005-04       Impact factor: 10.545

Review 6.  The burden of kidney disease: improving global outcomes.

Authors:  Garabed Eknoyan; Norbert Lameire; Rashad Barsoum; Kai-Uwe Eckardt; Adeera Levin; Nathan Levin; Francesco Locatelli; Alison MacLeod; Raymond Vanholder; Rowan Walker; Haiyan Wang
Journal:  Kidney Int       Date:  2004-10       Impact factor: 10.612

7.  Increased production of proinflammatory cytokines in adipose tissue of patients with end-stage renal disease.

Authors:  Tomas Roubicek; Marketa Bartlova; Jana Krajickova; Denisa Haluzikova; Milos Mraz; Zdena Lacinova; Michal Kudla; Vladimir Teplan; Martin Haluzik
Journal:  Nutrition       Date:  2009 Jul-Aug       Impact factor: 4.008

Review 8.  Social stress, visceral obesity, and coronary artery atherosclerosis: product of a primate adaptation.

Authors:  Carol A Shively; Thomas C Register; Thomas B Clarkson
Journal:  Am J Primatol       Date:  2009-09       Impact factor: 2.371

9.  Investigations into negative interference by jaundiced plasma in kinetic Jaffé methods for plasma creatinine determination.

Authors:  M L Knapp; O Hadid
Journal:  Ann Clin Biochem       Date:  1987-01       Impact factor: 2.057

10.  Association between metabolic syndrome and chronic kidney disease in perimenopausal women.

Authors:  Yongqiang Li; Liqin Zhao; Youming Chen; Aiqun Liu; Xinyu Liu; Xiaofei Shao; Ying Zhang; Honglei Wang; Xiaohong Wang; Bin Li; Kangping Deng; Qin Liu; Harry Holthöfer; Hequn Zou
Journal:  Int J Environ Res Public Health       Date:  2013-08-30       Impact factor: 3.390

View more
  10 in total

1.  Hypertriglyceridemic waist phenotype and abnormal glucose metabolism: a system review and meta-analysis.

Authors:  Chun-Ming Ma; Xiao-Li Liu; Na Lu; Rui Wang; Qiang Lu; Fu-Zai Yin
Journal:  Endocrine       Date:  2019-05-07       Impact factor: 3.633

2.  The Association Between Hypertriglyceridemic-Waist Phenotype and Chronic Kidney Disease in Patients with Type 2 Diabetes: A Cross-Sectional METAL Study.

Authors:  Yan Xuan; Wen Zhang; Yuying Wang; Bin Wang; Yi Chen; Fangzhen Xia; Kun Zhang; Qing Li; Ningjian Wang; Yingli Lu
Journal:  Diabetes Metab Syndr Obes       Date:  2022-06-20       Impact factor: 3.249

3.  Association of hypertriglyceridemic waist phenotype with renal function impairment: a cross-sectional study in a population of Chinese adults.

Authors:  Yun Qiu; Qi Zhao; Na Wang; Yuting Yu; Ruiping Wang; Yue Zhang; Shuheng Cui; Meiying Zhu; Xing Liu; Yonggen Jiang; Genming Zhao
Journal:  Nutr Metab (Lond)       Date:  2020-08-05       Impact factor: 4.169

4.  Hypertriglyceridemic waist phenotype and risk of chronic kidney disease in community-dwelling adults aged 60 years and older in Tianjin, China: a 7-year cohort study.

Authors:  Ruping Chen; Guangshan Sun; Rui Liu; Ao Sun; Yujie Cao; Xiaojie Zhou; Sha Zhang
Journal:  BMC Nephrol       Date:  2021-05-19       Impact factor: 2.388

5.  Visceral Adiposity Index and Lipid Accumulation Product Index: Two Alternate Body Indices to Identify Chronic Kidney Disease among the Rural Population in Northeast China.

Authors:  Dongxue Dai; Ye Chang; Yintao Chen; Shuang Chen; Shasha Yu; Xiaofan Guo; Yingxian Sun
Journal:  Int J Environ Res Public Health       Date:  2016-12-13       Impact factor: 3.390

6.  The Association of Hypertriglyceridemic Waist Phenotype with Chronic Kidney Disease and Its Sex Difference: A Cross-Sectional Study in an Urban Chinese Elderly Population.

Authors:  Jing Zeng; Miao Liu; Lei Wu; Jianhua Wang; Shanshan Yang; Yiyan Wang; Yao Yao; Bin Jiang; Yao He
Journal:  Int J Environ Res Public Health       Date:  2016-12-13       Impact factor: 3.390

7.  Visceral adiposity index is strongly associated with hyperuricemia independently of metabolic health and obesity phenotypes.

Authors:  Huimin Dong; Yang Xu; Xiuzhi Zhang; Simiao Tian
Journal:  Sci Rep       Date:  2017-08-18       Impact factor: 4.379

8.  Visceral, general, abdominal adiposity and atherogenic index of plasma in relatively lean hemodialysis patients.

Authors:  Chaomin Zhou; Hongying Peng; Jing Yuan; Xin Lin; Yan Zha; Hui Chen
Journal:  BMC Nephrol       Date:  2018-08-16       Impact factor: 2.388

9.  The association between hypertriglyceridemic-waist phenotype and chronic kidney disease: a cohort study and meta-analysis.

Authors:  Dezhong Chen; Huimin Sun; Ciyong Lu; Weiqing Chen; Vivian Yawei Guo
Journal:  Sci Rep       Date:  2022-02-04       Impact factor: 4.379

10.  The Relationship between Hypertriglyceridemic Waist Phenotype and Early Diabetic Nephropathy in Type 2 Diabetes.

Authors:  Chun-Ming Ma; Rui Wang; Xiao-Li Liu; Na Lu; Qiang Lu; Fu-Zai Yin
Journal:  Cardiorenal Med       Date:  2017-07-13       Impact factor: 2.041

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.